Evaluating Inappropriate Medication Prescribing Among Elderly Patients in Palestine Using the STOPP/ START Criteria

References

• Abukhalil AD, Shaloudi AY, Shamasneh NM, Aljamal AM. Awareness of Beers criteria and potentially inappropriate medications among physicians and pharmacists in Palestine. J Pharm Pract Res. 2021;51:381–389.
   Web of Science ®Google Scholar
• Chen N, Alam AB, Lutsey PL, et al. Polypharmacy, adverse outcomes, and treatment effectiveness in patients ≥75 with atrial fibrillation. J Am Heart Assoc. 2020;9:11. doi:10.1161/JAHA.119.015089
   Web of Science ®Google Scholar
• Ruscin JM. Aging and drugs - older people’s health issues - MSD manual consumer version; 2021. Available from: https://www.msdmanuals.com/home/older-people’s-health-issues/aging-and-drugs/aging-and-drugs#top. Accessed May 14, 2022.
   Google Scholar
• Locquet M, Honvo G, Rabenda V, et al. Adverse health events related to self-medication practices among elderly: a systematic review. Drugs Aging. 2017;34(5):359–365. doi:10.1007/s40266-017-0445-y
   PubMed Web of Science ®Google Scholar
• Long SJ, Brown KF, Ames D, Vincent CA. What is known about adverse events in older medical hospital inpatients? A systematic review of the literature. Int J Qual Health Car. 2013;25(5):542–554. doi:10.1093/intqhc/mzt056
   PubMed Web of Science ®Google Scholar
• Mira JJ. Medication errors in the older people population. Expert Rev Clin Pharmacol. 2019;12(6):491–494. doi:10.1080/17512433.2019.1615442
   PubMed Web of Science ®Google Scholar
• O'Mahony D, O'Sullivan D, Byrne S, O'Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2018;47(3):489. doi:10.1093/ageing/afu145
   Google Scholar
• O’Connor J, Adabavazeh B, Choi H, Khan A, Shah S, Shah S. Use of the STOPP and START criteria to address polypharmacy for elderly patients in University Hospital Lewisham clinical decisions unit. Hong Kong J Emerg Med. 2021;28(2):79–84. doi:10.1177/1024907919849358
   Web of Science ®Google Scholar
• Raosoft, Inc. Sample Size Calculator.. Available from: http://www.raosoft.com/samplesize.html. Accessed May 14, 2022.
   Google Scholar
• Institute Nc. NCI Comorbidity Index Overview. National cancer Institute; 2022.
   Google Scholar
• Charlson MEC. Comorbidity Index Calculator. Available from: https://www.mdcalc.com/charlson-comorbidity-index-cci. Accessed May 14, 2022.
   Google Scholar
• (MCHP) MCfHP. Manitoba centre. Charlson comorbidity index. Available from: http://mchp-appserv.cpe.umanitoba.ca/viewConcept.php?printer=Y&conceptID=1098. Accessed May 15, 2022.
   Google Scholar
• Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230. doi:10.1186/s12877-017-0621-2
   PubMed Web of Science ®Google Scholar
• Fahrni ML, Azmy MT, Usir E, Aziz NA, Hassan Y. Inappropriate prescribing defined by STOPP and START criteria and its association with adverse drug events among hospitalized older patients: a multicentre, prospective study. PLoS One. 2019;14(7):e0219898. doi:10.1371/journal.pone.0219898
   PubMed Web of Science ®Google Scholar
• Parsons C, Johnston S, Mathie E, et al. Potentially inappropriate prescribing in older people with dementia in care homes: a retrospective analysis. Drugs Aging. 2012;29(2):143–155. doi:10.2165/11598560-000000000-00000
   PubMed Web of Science ®Google Scholar
• Urzal J, Pedro AB, Oliveira IF, et al. Inappropriate prescribing to elderly patients in an internal medicine ward. Acta Med Port. 2019;32(2):141–148. doi:10.20344/amp.10683
   PubMed Web of Science ®Google Scholar
• Mohammed A, Ahmed KO, Yousef BA. Assessment of potentially inappropriate prescribed medications in older patients using STOPP/START criteria at soba university hospital: a descriptive retrospective study. J Pharm Care. 2022. doi:10.18502/jpc.v10i1.9122
   Google Scholar
• Baré M, Lleal M, Ortonobes S, et al. Factors associated to potentially inappropriate prescribing in older patients according to STOPP/START criteria: moPIM multicentre cohort study. BMC Geriatr. 2022;22:1. doi:10.1186/s12877-021-02715-8
   PubMed Web of Science ®Google Scholar
• Pereira TFF, Soares ADS, Trevisol DJ, Schuelter-Trevisol F. Assessing the overall medication use by elderly people in a Brazilian hospital using the start/stopp criteria version 2. Braz J Pharm Sci. 2019;55. doi:10.1590/s2175-97902019000117739
   Web of Science ®Google Scholar
• Mortazavi SS, Shati M, Keshtkar A, Malakouti SK, Bazargan M, Assari S. Defining polypharmacy in the elderly: a systematic review protocol. BMJ Open. 2016;6(3):e010989. doi:10.1136/bmjopen-2015-010989
   PubMed Web of Science ®Google Scholar
• Aging NIo. The dangers of polypharmacy and the case for deprescribing in older adults. Available from: https://www.nia.nih.gov/news/dangers-polypharmacy-and-case-deprescribing-older-adults. Accessed May 15, 2022.
   Google Scholar
• Apo.Who.Int. Medication safety in polypharmacy: technical report. Available from: https://www.who.int/publications/i/item/WHO-UHC-SDS-2019.11. Accessed May 14, 2022.
   Google Scholar
• Pazan F, Wehling M. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. Eur Geriatr Med. 2021;12(3):443–452. doi:10.1007/s41999-021-00479-3
   PubMed Web of Science ®Google Scholar
• Ryan C, O’Mahony D, Kennedy J, Weedle P, Byrne S. Potentially inappropriate prescribing in an Irish elderly population in primary care. Br J Clin Pharmacol. 2009;68(6):936–947. doi:10.1111/j.1365-2125.2009.03531.x
   PubMed Web of Science ®Google Scholar
• Kimura T, Ogura F, Yamamoto K, et al. Potentially inappropriate medications in elderly Japanese patients: effects of pharmacists’ assessment and intervention based on screening tool of older persons’ potentially inappropriate prescriptions criteria ver.2. J Clin Pharm Ther. 2017;42(2):209–214. doi:10.1111/jcpt.12496
   PubMed Web of Science ®Google Scholar
• Abu Farha RK, Mukattash TL, Al-Sakran L, Abu Hammour K, Zawiah M. Prevalence and predictors of polypharmacy in Jordanian hospitalised patients: a cross-sectional Study. Int J Clin Pract. 2021;75(4):e13742. doi:10.1111/ijcp.13742
   PubMed Web of Science ®Google Scholar
• Sakr S, Hallit S, Haddad M, Khabbaz LR. Assessment of potentially inappropriate medications in elderly according to Beers 2015 and STOPP criteria and their association with treatment satisfaction. Arch Gerontol Geriatr. 2018;78:132–138. doi:10.1016/j.archger.2018.06.009
   PubMed Web of Science ®Google Scholar
• Awad A, Hanna O. Potentially inappropriate medication use among geriatric patients in primary care setting: a cross-sectional study using the Beers, STOPP, FORTA and MAI criteria. PLoS One. 2019;14(6):e0218174. doi:10.1371/journal.pone.0218174
   PubMed Web of Science ®Google Scholar
• Huynh I, Rajendran T. Therapeutic duplication on the general surgical wards. BMJ Open Quality. 2021;10(3):e001363. doi:10.1136/bmjoq-2021-001363
   PubMedGoogle Scholar
• Pasina L, Astuto S, Cortesi L, et al. Therapeutic duplicates in a cohort of hospitalized elderly patients: results from the REPOSI study. Drugs Aging. 2016;33(9):647–654. doi:10.1007/s40266-016-0395-9
   PubMed Web of Science ®Google Scholar
• Hill-Taylor B, Walsh KA, Stewart S, Hayden J, Byrne S, Sketris IS. Effectiveness of the STOPP/START (Screening Tool of Older Persons’ potentially inappropriate Prescriptions/Screening Tool to Alert doctors to the Right Treatment) criteria: systematic review and meta-analysis of randomized controlled studies. J Clin Pharm Ther. 2016;41(2):158–169. doi:10.1111/jcpt.12372
   PubMed Web of Science ®Google Scholar
• Abdulghani KH, Aseeri MA, Mahmoud A, Abulezz R. The impact of pharmacist-led medication reconciliation during admission at tertiary care hospital. Int J Clin Pharm. 2018;40(1):196–201. doi:10.1007/s11096-017-0568-6
   PubMed Web of Science ®Google Scholar
• Redmond P, Grimes TC, McDonnell R, Boland F, Hughes C, Fahey T. Impact of medication reconciliation for improving transitions of care. Cochrane Database Syst Rev. 2018;2018:8. doi:10.1002/14651858.CD010791.pub2
   Web of Science ®Google Scholar
• Koziol KJ, Van der Merwe V, Yakiwchuk EM, Kosar L. Dual antiplatelet therapy for secondary stroke prevention: use of clopidogrel and acetylsalicylic acid after noncardioembolic ischemic stroke. Can Fam Physician. 2016;62(8):640–645.
   PubMed Web of Science ®Google Scholar
• Sherling DH, Perumareddi P, Hennekens CH. Metabolic Syndrome. J Cardiovasc Pharmacol Ther. 2017;22(4):365–367. doi:10.1177/1074248416686187
   PubMed Web of Science ®Google Scholar
• Greene SJ, Butler J, Albert NM, et al. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry. J Am Coll Cardiol. 2018;72(4):351–366. doi:10.1016/j.jacc.2018.04.070
   PubMed Web of Science ®Google Scholar
• Lim SY. Role of statins in coronary artery disease. Chonnam Med J. 2013;49(1):1-6. doi:10.4068/cmj.2013.49.1.1.
   Google Scholar
• Gillespie EL, White CM, Kardas MJ, Lindberg M, Coleman CI. The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes. Diabetes Care. 2005;28(9):2261–2266. doi:10.2337/diacare.28.9.2261
   PubMed Web of Science ®Google Scholar
• Patel D, Ackermann RJ. Issues in geriatric care: falls. FP Essent. 2018;468:18–25.
   PubMedGoogle Scholar
• Bergen G, Stevens MR, Burns ER. Falls and fall injuries among adults aged ≥65 years - united states, 2014. MMWR Morb Mortal Wkly Rep. 2016;65(37):993–998. doi:10.15585/mmwr.mm6537a2
   PubMed Web of Science ®Google Scholar
• Tosetti C, Nanni I. Use of proton pump inhibitors in general practice. World J Gastrointest Pharmacol Ther. 2017;8(3):180–185. doi:10.4292/wjgpt.v8.i3.180
   PubMedGoogle Scholar